@article{moe_marked_2025,
	title = {Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study},
	volume = {25},
	issn = {1471-230X},
	shorttitle = {Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease},
	url = {https://doi.org/10.1186/s12876-025-03944-6},
	doi = {10.1186/s12876-025-03944-6},
	abstract = {Mechanisms causing non-response to biological agents in IBD remain to be fully understood. Thus, we aimed to characterize the lipid profile in treatment refractory non-immunogenic patients with adequate trough-levels.},
	number = {1},
	urldate = {2025-05-23},
	journal = {BMC Gastroenterology},
	author = {Moe, Øystein K. and Gao, Qian and Geng, Dawei and Jensen, Einar and Goll, Rasmus and Nestegard, Oddmund and Gundersen, Mona D. and Florholmen, Jon R. and Moritz, T.},
	month = may,
	year = {2025},
	keywords = {Biological therapy, Inflammatory bowel disease, Lipids, Non-response},
	pages = {389},
}

{"_id":"mqN9izg4G4mf23dkd","bibbaseid":"moe-gao-geng-jensen-goll-nestegard-gundersen-florholmen-etal-markedmucosallipidshiftsintreatmentrefractoryinflammatoryboweldiseasealipidomicstudy-2025","author_short":["Moe, Ø. K.","Gao, Q.","Geng, D.","Jensen, E.","Goll, R.","Nestegard, O.","Gundersen, M. D.","Florholmen, J. R.","Moritz, T."],"bibdata":{"bibtype":"article","type":"article","title":"Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study","volume":"25","issn":"1471-230X","shorttitle":"Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease","url":"https://doi.org/10.1186/s12876-025-03944-6","doi":"10.1186/s12876-025-03944-6","abstract":"Mechanisms causing non-response to biological agents in IBD remain to be fully understood. Thus, we aimed to characterize the lipid profile in treatment refractory non-immunogenic patients with adequate trough-levels.","number":"1","urldate":"2025-05-23","journal":"BMC Gastroenterology","author":[{"propositions":[],"lastnames":["Moe"],"firstnames":["Øystein","K."],"suffixes":[]},{"propositions":[],"lastnames":["Gao"],"firstnames":["Qian"],"suffixes":[]},{"propositions":[],"lastnames":["Geng"],"firstnames":["Dawei"],"suffixes":[]},{"propositions":[],"lastnames":["Jensen"],"firstnames":["Einar"],"suffixes":[]},{"propositions":[],"lastnames":["Goll"],"firstnames":["Rasmus"],"suffixes":[]},{"propositions":[],"lastnames":["Nestegard"],"firstnames":["Oddmund"],"suffixes":[]},{"propositions":[],"lastnames":["Gundersen"],"firstnames":["Mona","D."],"suffixes":[]},{"propositions":[],"lastnames":["Florholmen"],"firstnames":["Jon","R."],"suffixes":[]},{"propositions":[],"lastnames":["Moritz"],"firstnames":["T."],"suffixes":[]}],"month":"May","year":"2025","keywords":"Biological therapy, Inflammatory bowel disease, Lipids, Non-response","pages":"389","bibtex":"@article{moe_marked_2025,\n\ttitle = {Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study},\n\tvolume = {25},\n\tissn = {1471-230X},\n\tshorttitle = {Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease},\n\turl = {https://doi.org/10.1186/s12876-025-03944-6},\n\tdoi = {10.1186/s12876-025-03944-6},\n\tabstract = {Mechanisms causing non-response to biological agents in IBD remain to be fully understood. Thus, we aimed to characterize the lipid profile in treatment refractory non-immunogenic patients with adequate trough-levels.},\n\tnumber = {1},\n\turldate = {2025-05-23},\n\tjournal = {BMC Gastroenterology},\n\tauthor = {Moe, Øystein K. and Gao, Qian and Geng, Dawei and Jensen, Einar and Goll, Rasmus and Nestegard, Oddmund and Gundersen, Mona D. and Florholmen, Jon R. and Moritz, T.},\n\tmonth = may,\n\tyear = {2025},\n\tkeywords = {Biological therapy, Inflammatory bowel disease, Lipids, Non-response},\n\tpages = {389},\n}\n\n\n\n","author_short":["Moe, Ø. K.","Gao, Q.","Geng, D.","Jensen, E.","Goll, R.","Nestegard, O.","Gundersen, M. D.","Florholmen, J. R.","Moritz, T."],"key":"moe_marked_2025","id":"moe_marked_2025","bibbaseid":"moe-gao-geng-jensen-goll-nestegard-gundersen-florholmen-etal-markedmucosallipidshiftsintreatmentrefractoryinflammatoryboweldiseasealipidomicstudy-2025","role":"author","urls":{"Paper":"https://doi.org/10.1186/s12876-025-03944-6"},"keyword":["Biological therapy","Inflammatory bowel disease","Lipids","Non-response"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/upscpub","dataSources":["9cGcv2t8pRzC92kzs"],"keywords":["biological therapy","inflammatory bowel disease","lipids","non-response"],"search_terms":["marked","mucosal","lipid","shifts","treatment","refractory","inflammatory","bowel","disease","lipidomic","study","moe","gao","geng","jensen","goll","nestegard","gundersen","florholmen","moritz"],"title":"Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study","year":2025}